Pediatrics
News
CHMP recommends approval of nilotinib for kids
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the authorized use for nilotinib (...
News
Report details progress, obstacles in cancer research and care
Deaths from cancer are on the decline in the US, but new cases of cancer are on the rise, according to the 7th annual American Association for...
News
Withdrawn AML drug back on market in US
The US Food and Drug Administration (FDA) has approved use of gemtuzumab ozogamicin (GO, Mylotarg), a treatment that was initially approved by the...
News
FDA reapproves gemtuzumab ozogamicin for CD33-positive AML treatment
Initial approval for gemtuzumab ozogamicin was granted in May 2000 as a stand-alone treatment for CD33-positive AML in older patients, but was...
News
Young cancer patients want more digital support, survey says
A recent survey of young cancer patients in the UK revealed their desire for additional digital oncology resources. The survey showed that many...
News
FDA approves first gene therapy – tisagenlecleucel for ALL
“New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to...
Conference Coverage
CANTOS sings of novel strategy for cardiovascular, cancer prevention
BARCELONA – Targeted anti-inflammatory therapy with canakinumab showed diverse clinical benefits.
News
High healthcare costs follow CCSs into adulthood
New research suggests survivors of childhood cancer can incur high out-of-pocket medical costs into adulthood and may forgo healthcare to lessen...
News
Drug granted orphan designation for chemo-induced ototoxicity
The US Food and Drug Administration (FDA) has granted orphan drug designation to SENS-401 to be used for the prevention of platinum-induced...
From the Journals
Crizotinib shows responses in pediatric ALCL and IMT
Eighty percent of ALK-positive anaplastic large cell lymphoma patients in the high-dose group had a complete response, along with 83% given the...
From the Journals
HPV vaccination rose after ACA implementation
Is there more that physicians can do to maintain the increase in HPV vaccinations?